A COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDER
双相情感障碍的合作基因组研究
基本信息
- 批准号:2891158
- 负责人:
- 金额:$ 24.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:behavioral genetics bipolar depression cell line clinical research computer assisted sequence analysis computer data analysis computer program /software cryopreservation diagnosis quality /standard family genetics genetic markers genetic registry /resource /referral center genetic susceptibility genome genotype human data human genetic material tag human subject information systems interview linkage mapping mental disorder diagnosis phenotype
项目摘要
DESCRIPTION: (Adapted from investigator's abstract) Bipolar affective
disorder is a severe heritable condition affecting about one percent of
the population. The mode of inheritance is poorly understood and probably
involves multiple loci of small to moderate effect. Genetic linkage
studies have not been robust although some reports of linkages have been
replicated several times. The NIMH began a national archival database for
search of linked genes in this condition in 1988. Its purpose was to
collect a large sample of interviews and cell lines from families suitable
for linkage and association studied. Four centers participated in the
initiative: Indiana University, John Hopkins University, Washington
University of St. Louis, and the NIMH Intramural Program. A new structured
polydiagnostic interview, the Diagnostic Interview for Genetic Studies
(DIGS), was developed and field-tested. Ascertainment was begun in 1999 to
identify Bipolar I (BPI) probands with a BPI or Schizoaffective, Bipolar
type (Sa/BP) first degree relative. Two hundred and forty-three families
have been enrolled in the program including 1025 affected subjects. Twenty
on hundred sixty five structured interviews have been given and 2097
immortalized cell lines have been cryopreserved. A genomic survey has been
completed on 540 subjects selected from 97 families and eight candidate
areas for linkage have been identified, some supporting previous findings.
These cell lines and related clinical information has been publicly
released. A follow-up sample is presently being genotyped, with
particular attention to areas of interest identified in the original
survey.
It is proposed to extend the present study through families identified by
a BPI/BPI sib pair at eight sites (Indiana, Washington University of St.
Louis, Johns Hopkins, University of Pennsylvania, University of
California, San Diego , University of Utah, University of Chicago, and
University of Iowa). A total of 450 new families and 2500 cell lines and
interviews over the next four years will be added. This sample will be
used to confirm and extend present findings of linkage, to narrow the
implicated regions, and to test candidate genes. Genotypes will be shared
with a consortium of investigators studying linkage in bipolar illness.
Cell lines and interview data will be made freely available to the
scientific community.
描述:(改编自研究者的摘要)双相情感
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Henry Coryell其他文献
William Henry Coryell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Henry Coryell', 18)}}的其他基金
Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MMD
产前 MMD 的细胞因子、PUFA 组织浓度和治疗选择
- 批准号:
8265810 - 财政年份:2011
- 资助金额:
$ 24.37万 - 项目类别:
Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MMD
产前 MMD 的细胞因子、PUFA 组织浓度和治疗选择
- 批准号:
8028436 - 财政年份:2011
- 资助金额:
$ 24.37万 - 项目类别:
Pilot Study of Omega-3 Fatty Acid in Depressive Disorder
Omega-3 脂肪酸治疗抑郁症的初步研究
- 批准号:
7040784 - 财政年份:2004
- 资助金额:
$ 24.37万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6843721 - 财政年份:1998
- 资助金额:
$ 24.37万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
7154081 - 财政年份:1998
- 资助金额:
$ 24.37万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6989781 - 财政年份:1998
- 资助金额:
$ 24.37万 - 项目类别:
相似海外基金
Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
- 批准号:
486939 - 财政年份:2023
- 资助金额:
$ 24.37万 - 项目类别:
Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
- 批准号:
486443 - 财政年份:2022
- 资助金额:
$ 24.37万 - 项目类别:
Studentship Programs
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
- 批准号:
486577 - 财政年份:2022
- 资助金额:
$ 24.37万 - 项目类别:
Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
- 批准号:
2748645 - 财政年份:2022
- 资助金额:
$ 24.37万 - 项目类别:
Studentship
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
- 批准号:
469571 - 财政年份:2022
- 资助金额:
$ 24.37万 - 项目类别:
Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
- 批准号:
444068 - 财政年份:2021
- 资助金额:
$ 24.37万 - 项目类别:
Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
- 批准号:
434675 - 财政年份:2020
- 资助金额:
$ 24.37万 - 项目类别:
Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
- 批准号:
9555300 - 财政年份:2018
- 资助金额:
$ 24.37万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10080262 - 财政年份:2018
- 资助金额:
$ 24.37万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10588254 - 财政年份:2018
- 资助金额:
$ 24.37万 - 项目类别:














{{item.name}}会员




